WALTHAM, Mass. - Q32 Bio Inc. (NASDAQ: QTTB), a clinical-stage biotechnology firm trading at $3.18 with a market cap of $38.55 million, announced a strategic shift to prioritize the development of its ...
Q32 Bio (QTTB) announced a corporate restructuring to focus on the advancement of its bempikibart clinical development program for the ...
Q32 Bio Inc. (Nasdaq: QTTB) ("Q32 Bio"), a clinical stage biotechnology company focused on developing biologic therapeutics to restore immune homeostasis, today announced a corporate restructuring to ...
Atopy from food allergies to environmental factors can increase hair loss prevalence among children and adults, according to ...
SAN FRANCISCO - Nektar Therapeutics (NASDAQ:NKTR) announced today that its drug candidate, rezpegaldesleukin, has received Fast Track designation from the U.S. Food and Drug Administration (FDA) for ...
A NEW mum who wanted a new bust after having her baby has lost all of her hair following the operation – including her eyelashes and eyebrows. The silicone implants Czech dental worker ...
بعض نتائج کو اس وجہ سے چھپا دیا گیا ہے کیونکہ ممکن ہے آپ کو ان تک رسائی حاصل نہ ہو۔
ناقابل رسائی نتائج دکھائیں۔